ArticleLupus science & medicine2022

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.

Diane L Kamen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.